Nature's Way - Chromium Picolinate, 200 mcg
Chromium is an essential part of the GTF (glucose tolerance factor)
molecule. GTF is an important cofactor for insulin in the regulation of
blood sugar which is necessary for proper metabolism.
Nature's Way Chromium Picolinate is 100% natural, patented Chromium
Picolinate. It contains no artificial ingredients or preservatives.
Click here to buy Chromium supplement,
FREE Diet Rx with
chromium picolinate, or to sign up to a
highly respected and FREE newsletter
FREE Diet Rx Bottle
You can find chromium in an excellent doctor-formulated
multivitamin product.
High Quality products formulated by a
medical doctor


Mind Power Rx for better
mental focus, concentration, and mood; Diet Rx
with chromium picolinate
and
Green Tea Extract
which helps you eat less. It really does curb appetite; Good Night
Rx for better sleep; Eyesight
Rx for better vision, often within days; MultiVit
Rx, a daily comprehensive multivitamin for more energy and
vitality; Joint Power Rx
for healthy joints; Prostate Power Rx
for a healthy prostate gland; and Passion Rx
for sexual enhancement, better libido, and improved performance and stamina in men and women.
Dr. Nanno
Kleefstra from Isala Clinics in Zwolle, and colleagues investigated the effects
of chromium in people with type 2 diabetes residing in a northern region of the
Netherlands. Fifty-seven patients were randomly assigned to take 400 micrograms
of chromium per day or a placebo. After 3 and 6 months of treatment, there were
no differences between the chromium group and the placebo group for fasting
blood glucose levels, long-term control of glucose levels as measured by A1c,
blood pressure, body fat percentage, weight, lipid profile, and how well they
responded to the insulin their bodies produced, the investigators report in the
medical journal Diabetes Care. Diabetes Care, May 2007.
Availability of Chromium
Chromium is available in a variety of dosages and forms, most commonly in 100 or
200 mcg. A dosage of 100 to 200 mcg of chromium could be taken by healthy
individuals a couple of times a week, while those with diabetes may benefit from
taking chromium 3 to 5 times a week. A combination of chromium picolinate and
biotin is found in a patented formula called
Diachrome.
Chromium Research update
Effectiveness of chromium in atypical depression: a placebo-controlled trial.
Davidson JR,. Duke University Medical
Center, Durham, North Carolina 27710, USA.
Biol Psychiatry. 2003 Feb 1;53(3):261-4.
Chromium picolinate (CP) has been reported to benefit patients with
symptoms of atypical depression. METHODS: A placebo-controlled, double-blind,
pilot study of CP was conducted in 15 patients with DSM-IV major depressive
disorder, atypical type. Patients received 600 micro g of CP or matching placebo
(PBO) for 8 weeks. RESULTS: Seven (70%) CP and zero (0%) PBO patients met
responder criteria. Other outcomes were consistent with greater effect
of CP. Three patients on CP failed to show any improvement. Chromium picolinate
was well tolerated. Chromium picolinate shows promising
antidepressant effects in atypical depression. Its mechanism of action may
relate to 5HT2A downregulation, increased insulin sensitivity, or to other
effects.
Beneficial effects of chromium in people with type 2 diabetes, and urinary
chromium response to glucose load as a possible indicator of status.
Bahijri SM, Mufti AM.
King Abdulaziz University, Jeddah, Saudi Arabia.
Biol Trace Elem Res. 2002 Feb;85(2):97-109.
No reliable method for the estimation of chromium (Cr) status is available yet.
The aim of this study is to investigate the possibility of using urinary Cr
response to glucose load as an indicator of Cr status. Seventy-eight
non-insulin-dependent diabetes mellitus patients, were divided randomly into two
groups and given Cr supplements as brewer's yeast and CrCl3 sequentially with
placebo in between, in a double-blind, crossover design of four stages, each
lasting 8 wk. At the beginning and end of each stage, subjects were weighed,
their dietary data and drug dosage recorded, and blood and urine samples
collected for analysis of glucose and urinary chromium (fasting and 2 h
post-75-g glucose load) and fructosamine. The mean urinary Cr after the glucose
load was significantly higher than the fasting mean at zero time.
However, only 52 of the patients showed an obvious increase; the others showed a
slight decrease or no change. Both supplements caused a significant increase in
the means of urinary Cr and a significant decrease in the means of glucose and fructosamine. Only those subjects responding to Cr supplement by improved
glucose control showed an increase in post-glucose-load urinary Cr over fasting
level, after the supplement but not at zero time. Therefore, it was concluded
that urinary Cr response to glucose load could be used as an indicator of Cr
status.